<DOC>
	<DOCNO>NCT00595153</DOCNO>
	<brief_summary>The purpose study identify cause asthma previously suspect , good understand effect inhale steroid asthma identify new way treat asthma . In order take advantage current scientific expertise , ( scientist UCSF ) plan work together Genentech Inc. We believe work Genentech provide best chance develop new treatment asthma .</brief_summary>
	<brief_title>Study Mechanisms Asthma</brief_title>
	<detailed_description>Asthma common airway disease persistent unmet need term treatment . Although many asthmatic enjoy good control disease use regularly schedule corticosteroid treatment , significant minority achieve optimal control steroid suffer asthma exacerbation severe even fatal . Asthma pathophysiology complex involve multiple cell type multiple signal mechanism . One approach complexity study response isolate airway cell experimental condition model asthmatic inflammation ; another genetic manipulation candidate mediator asthma inbred mouse . These study yield important insight possible mechanism asthma human , relevance mechanism human disease always proven , possible unsuspected mechanism yet reveal approach . In study propose take experimental approach take advantage distinct clinical phenotype human asthma , ability measure steroid response asthma , relative ease collect airway cell tissue bronchoscopy , availability new technology high density microarrays probe gene genome proteomics identify protein present biologic sample . Using approach , identify differential expression gene proteins airway cell tissue asthma explore cell animal model system determine potential drug target asthma . We believe approach identify previously unsuspected mechanism action corticosteroid airway cell tissue asthma . Presently , relatively little known asthmatic respond well poorly steroid close gap knowledge help identify candidate gene protein target order address unmet therapeutic need asthmatic steroid resistant asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Group C : Male female subject age 18 70 year History asthma Continuous treatment inhale corticosteroid least 6week Hyperreactivity methacholine ( provocative concentration methacholine cause 20 % drop force expiratory volume 1 second ( PC20 FEV1 ) Methacholine ≤ 16.0 mg/mL ) . History asthma No use oral inhale corticosteroid treatment asthma past 6 week Hyperreactivity methacholine ( PC20 FEV1 Methacholine ≤ 8.0 mg/mL ) . At least one follow symptom , beta agonist use , FEV1 criterion : Asthma symptom least two day per week ; OR Beta agonist use least two day per week ; OR Forced expiratory volume 1 second ( FEV1 ) &lt; 85 % predicted Subjects must nonsmoker ( patient never smoke patient smoke 1 year total packyear smoke history &lt; 15 pack ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>